Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.
N E U HermansenR BorupM K AndersenA J VangstedN T ClausenD L KristensenF C NielsenPeter GimsingPublished in: International journal of laboratory hematology (2016)
Translated GEP risk signatures maintain significant prognostic power in HDT myeloma patients. We suggest probe set matching for GEP risk signature translation as part of the efforts towards a microarray-independent GEP risk standard. (ClicinalTrials.gov identifier: NCT00639054).